Shishido, Stephanie N.
Suresh, Divya
Courcoubetis, George
Ye, Brandon
Lin, Emmeline
Mason, Jeremy
Park, Ken
Lewis, Michael
Wang, Ruoxiang
Lo, Simon K.
Kuhn, Peter
Pandol, Stephen
Funding for this research was provided by:
USC Michelson Center Convergent Science Institute in Cancer (None, None)
USC Provost Research Fellowship (None, None, None)
National Cancer Institute (5P30CA014089-40, 5P30CA014089-40)
Cedars-Sinai Board of Counselors Grant (None)
the F. Widjaja Family Chair (None)
the Widjaja Family Fund (None)
Vassiliadis Research Fund (None)
Vicky Joseph Research Fund (None)
Hart Family Research Fund (None)
Article History
Received: 13 February 2024
Revised: 22 May 2024
Accepted: 2 June 2024
First Online: 27 June 2024
Competing interests
: The HDSCA technology described here is licensed to Epic Sciences. P.K. has ownership in Epic Sciences. All other authors declare no conflict of interest.
: This study was approved by the Cedars-Sinai Medical Center IRB (Pro00041571). Informed consent was obtained from all subjects.